Synthetic Cannabinoids: What The Term Covers

One word, two very different things

1. Hemp's own cannabinoids form a known, catalogued family, described compound by compound in the chemical literature [1]. Synthetic cannabinoids are built in a laboratory, and where they are sold with no regulation behind them, the contents shift from batch to batch.
2. The first group has a plain job. These are research compounds, made so that receptor signalling can be studied under controlled conditions, with a known concentration and a characterised molecule.
3. Those receptors were put on record in 1990, when a research team reported the structure of a cannabinoid receptor along with the functional expression of the cloned cDNA [2].
4. The word synthetic describes origin and nothing else. It tells you where a molecule was assembled. It says nothing about how well characterised that molecule is.
5. Batch-to-batch variation is the practical problem with unregulated synthetics. The same name printed on two packages is no promise of the same contents inside them.
6. Everything published about the plant family sits in open chemical literature, which is exactly what an unregulated batch has no access to [1].
7. Reading a name is not reading a report. A lot analysis says what a bottle holds. A product name only says what someone chose to call it.
8. Our catalogue holds plant cannabinoids only. That is a catalogue fact, not a position taken after the question came up.
9. One standard has run through the work since 2014: know what is inside, then declare it.

Made for the bench, not for a shelf

The clearest group to describe is also the least commercial. Research compounds are made so that receptor signalling can be studied under controlled conditions. Controlled means the concentration is known, the timing is known, and the compound itself is characterised before anybody measures anything at all. A tool molecule earns its place by being predictable, not by being interesting.

The reason such tools exist goes back to one specific piece of work. In 1990, Matsuda and colleagues reported the structure of a cannabinoid receptor together with the functional expression of the cloned cDNA [2]. Two things arrived at once there. A receptor with a described structure, and a laboratory copy of the genetic instructions for building it, expressed in cells so the receptor could be studied directly rather than inferred from a distance.

That combination changed the kind of question a researcher could ask. Before it, the target is an assumption. After it, the target is defined and sits in cells that can be grown, dosed and measured. Compounds designed for that setting are made to a specification and handled by people who know exactly what is in the vial.

None of this describes a consumer product. A research compound is a molecule plus its documentation, used inside a protocol. Roughly the distance between a reference standard in an analytical lab and a bottle in a kitchen cupboard.

When one name covers many mixtures

The trouble starts where synthetics leave the laboratory and turn up in unregulated sale. There, the defining feature is batch-to-batch variation. Two packages can share a name, a colour and a slogan, and still hold different contents. Nobody has committed to a specification, so there is nothing for a batch to be checked against.

Set that beside hemp's own cannabinoids. They are a known, catalogued family, described compound by compound in the chemical literature [1]. A named plant cannabinoid has a structure on record, a place in that catalogue, and analytical methods built around it. When CBD or CBG appears on one of our labels, the name points at something already defined well outside our company.

An unregulated synthetic has no such anchor. The name may have been invented for the packaging. The molecule may change between production runs. Even where a chemical name is printed, no independent record connects it to what is actually in the container.

So the useful questions are the dull ones. Which compound? Which batch? Measured by whom, using which method? Where one of those answers is missing, the honest description of the contents is unknown. That is not a claim about anything. It is simply an absence of information, and it is worth naming as such.

The plant family, compound by compound

Plant-derived work starts from a different position, and the difference is documentary rather than philosophical. The cannabinoids hemp makes on its own have been isolated, named and described over decades of chemistry. The 2005 review by ElSohly and Slade gathered that material and set out the plant's natural cannabinoids as a complex mixture of many identified constituents rather than one single compound [1]. That review is not marketing. It is a reference point anyone can look up.

A record that predates the market

This matters for a practical reason. When a compound already has a published identity, an analysis can confirm whether it is present and in what quantity. The name on the label and the line on the report describe the same thing. The catalogued family and the described receptor also sit in the same body of literature, since the 1990 work of Matsuda and colleagues gave that chemistry a defined target to be studied against [2]. Two separate records, both public, both older than most brands in this category. An unregulated synthetic batch has neither, and no route to acquiring them after the fact.

What our catalogue contains

Straight answer, because it is the question people actually ask. Cibdol products contain plant cannabinoids only. No synthetic cannabinoids are sold here, in any product, in any strength. That is a description of the catalogue as it stands, not a promise about the future of some other company's shelf.

We have been working with cannabinoids since 2014, back when the category still needed explaining to almost everyone who heard the word. Plenty has changed since then. Extraction methods, formats, the range of compounds we work with, the analytical equipment available.

Since 2014, one standard

The standard has not moved. Know what is inside, then declare it. In practice that means named compounds with a published chemical identity behind them [1], a batch number on the bottle, and an independent analysis you can read before the product becomes part of anything. Claims are cheap to write. A lot report is harder to produce and far more useful to hold.

If you are comparing products and the contents cannot be verified anywhere, that on its own tells you something. Swiss precision, in this context, is mostly a filing habit applied consistently for a long time.